Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Gut Liver ; 11(5): 655-666, 2017 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-28651306

RESUMO

BACKGROUND/AIMS: In inflammatory bowel disease (IBD), repeated bouts of remission and relapse occur in patients and can impose a risk of colitis-associated cancer. We hypothesized that plant extracts of Atractylodes macrocephala (AM) or Taraxacum herba (TH) may be better than sulfasalazine for treating this disease because these extracts can promote additional regeneration. METHODS: Murine intestinal epithelial IEC-6 cells were pretreated with AM or TH before a lipopolysaccharide (LPS)-induced challenge. Acute colitis was induced with 7 days of dextran sulfate sodium (DSS) in male C57BL/6 mice, and extracts of AM and TH were administered for 2 weeks before DSS administration. RESULTS: In vitro studies demonstrated that AM or TH treatment reduced LPS-induced COX-2 and tumor necrosis factor-α mRNA levels but increased heme oxygenase-1 (HO-1). Oral preadministration of AM and TH rescued mice from DSS-induced colitis by inhibiting inflammatory mediators via inactivated extracellular signal regulated kinase and repressed nuclear factor κB and signal transducer and activator of transcription 3, but the effect was weaker for sulfasalazine than that for the extracts. Anti-inflammatory activities occurred via the inhibition of macrophage and T lymphocyte infiltrations. Unlike sulfasalazine, which did not induce HO-1, TH extracts afforded significant HO-1 induction. CONCLUSIONS: Because the AM or TH extracts were far superior in preventing DSS-induced colitis than sulfasalazine, AM or TH extracts can be considered natural agents that can prevent IBD relapse.


Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Atractylodes/química , Colite/tratamento farmacológico , Heme Oxigenase-1/biossíntese , Proteínas de Membrana/biossíntese , Fitoterapia , Extratos Vegetais/farmacologia , Taraxacum/química , Animais , Colite/induzido quimicamente , Colite/prevenção & controle , Ciclo-Oxigenase 2/biossíntese , Sulfato de Dextrana , Indução Enzimática/efeitos dos fármacos , Mediadores da Inflamação/antagonistas & inibidores , Lipopolissacarídeos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Prevenção Secundária/métodos , Sulfassalazina/farmacologia , Fator de Necrose Tumoral alfa/biossíntese
2.
J Med Food ; 11(3): 479-85, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18800895

RESUMO

The biochemical mechanisms of Chlorella vulgaris protection against cadmium (Cd)-induced liver toxicity were investigated in male Sprague-Dawley rats (5 weeks of age, weighing 90-110 g). Forty rats were randomly divided into one control and three groups treated with 10 ppm Cd: one Cd without Chlorella (Cd-0C), one Cd with 5% Chlorella (Cd-5C), and one Cd with 10% Chlorella (Cd-10C) groups. The rats had free access to water and diet for 8 weeks. Body weight gain and relative liver weight were significantly lower in the Cd-0C group than in Cd-5C and Cd-10C groups. Rats in the Cd-0C group had significantly higher hepatic concentrations of Cd and metallothioneins (MTs) than in the Cd-5C or Cd-10C group. The hepatic MT I/II mRNA was expressed in all experimental rats. MT II was more expressed in the Cd-5C and Cd-10C groups than in the Cd-0C group. Morphologically, a higher level of congestion and vacuolation was observed in the livers of the Cd-0C group compared to those of the Cd-5C and Cd-10C groups. Therefore, this study suggests that C. vulgaris has a protective effect against Cd-induced liver damage by reducing Cd accumulation and stimulating the expression of MT II in liver. However, the details of the mechanism of C. vulgaris on liver toxicity remains to be clarified by further studies.


Assuntos
Intoxicação por Cádmio/tratamento farmacológico , Cádmio/metabolismo , Chlorella vulgaris , Hepatopatias/prevenção & controle , Fígado/fisiopatologia , Metalotioneína/genética , Metalotioneína/metabolismo , Animais , Peso Corporal/efeitos dos fármacos , Cádmio/toxicidade , Intoxicação por Cádmio/genética , Doença Hepática Induzida por Substâncias e Drogas , Suplementos Nutricionais , Hepatócitos , Hiperemia , Fígado/efeitos dos fármacos , Masculino , Tamanho do Órgão , Pós , Ratos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA